The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a warning about a counterfeit batch of Giga-S injections found in Aba, Abia State.
Giga-S Injection (Ceftriaxone + Sulbactam Inj. 1.5g IM/IV) is prescribed for severe infections caused by susceptible organisms, including septicemia, pneumonia, and meningitis. NAFDAC’s statement emphasizes that this fake product may have been distributed beyond Abia State, potentially reaching other parts of the country through informal markets.
“Although this falsified batch product was identified in Abia State, it may likely have been distributed to other parts of the country through informal markets. Consequently, it is important to detect and remove it from circulation to prevent harm to patients,” NAFDAC stated.
NAFDAC’s Call to Action
NAFDAC urges importers, distributors, retailers, and healthcare providers to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and administration of falsified or substandard medicinal products. All medical products should be sourced from authorized or licensed suppliers, and the authenticity and physical condition of the products should be carefully checked.
The agency also advises the public to discontinue the sale or use of the counterfeit product and submit any stock to the nearest NAFDAC office.
“If you have this counterfeit product, please DO NOT use it. If you or anyone you know has used this product or suffered any adverse reaction/event after use, seek immediate medical advice from a qualified healthcare professional,” NAFDAC added.
Reporting Suspicious Products and Adverse Effects
Healthcare professionals and consumers are encouraged to report any suspicious substandard and falsified medicines to the nearest NAFDAC office. Reports can also be made to NAFDAC via:
- Phone: 0800-162-3322
- Email: sf.alert@nafdac.gov.ng
Additionally, adverse events or side effects related to medicinal products can be reported through:
- The NAFDAC website: www.nafdac.gov.ng
- The Med-Safety app, available for download on Android and iOS
- Email: pharmacovigilance@nafdac.gov.ng
This notice will also be uploaded to the WHO Global Surveillance and Monitoring System (GSMS) to enhance global awareness and response.
NAFDAC reiterates its commitment to ensuring the safety and health of Nigerians by preventing the circulation of counterfeit medical products.
